Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 5 years
- Director since
- 2023
5 years of board service in total across 2 boards, counting each seat separately. Longest: BioMarin Pharmaceutical Inc., 3 years.
BioMarin Pharmaceutical Inc.
Director
Palvella Therapeutics Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Feb 27, 2026 | Palvella Therapeutics Inc. | Open-market purchase | +2,400 | $125.00 | $300,000 |
| Jun 3, 2024 | BioMarin Pharmaceutical Inc. | Option exercise | +5,047 | $63.10 | $318,466 |
| Jun 3, 2024 | BioMarin Pharmaceutical Inc. | Shares withheld for tax | −4,168 | $76.41 | $318,477 |
| May 21, 2024 | BioMarin Pharmaceutical Inc. | Grant or award | +4,720 | — | — |
| May 23, 2023 | BioMarin Pharmaceutical Inc. | Grant or award | +4,190 | — | — |
| May 12, 2023 | BioMarin Pharmaceutical Inc. | Option exercise | +8,500 | $67.81 | $576,385 |
| May 12, 2023 | BioMarin Pharmaceutical Inc. | Shares withheld for tax | −6,137 | $93.93 | $576,448 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.